Mohr Davidow Ventures
As a general partner at MDV, Michael Goldberg leverages valuable entrepreneur and investor experience from his more than 25 years of work in the life sciences industry including biotechnology, pharmaceuticals, health services and healthcare information technology. In addition to pursuing life sciences investments for MDV he works to extend the firm's reach into major universities and research centers.
Prior to joining MDV Michael was Managing Director of Jasper Capital and Co-chair of the California Research and Cures Coalition ($3 billion Prop 71 stem cell campaign). He has also held senior management and operations roles including serving as Chairman of OnCare, an oncology practice management company he founded in 1995. Until 1999 he also served as OnCare's Chief Executive Officer, where he guided revenue growth to $100 million in three years.
Previously, Michael was Founder and Chief Executive Officer of Axion Inc., a cancer-focused healthcare service company he started in 1987 and sold to Bristol-Myers Squibb in 1996. Axion ranked number four on Inc. Magazine's list of the 500 fastest growing private companies in America for the five years ended 1994. Michael was also a recipient of Inc. Magazine's 1995 Entrepreneur of the Year Award. Prior to his tenure with Axion, Michael was a partner in the venture capital firm Sevin Rosen Funds, where he was responsible for the firm's investments in the biomedical industry.
Michael received a B.A. from Brandeis University and an M.B.A. from Stanford Graduate School of Business.
Related Links: www.mdv.com
Last Updated: Thu, Jun 8, 2006
| Category | Title | Author/Speaker | Organization | Length | Date |
|---|---|---|---|---|---|
| Video | Career Advice | Michael Goldberg | MDV | 01:36 | 02/2006 |
| Video | Conflict Between Management Team and Board Members | Michael Goldberg | MDV | 01:47 | 02/2006 |
| Video | Importance of Patents and Intellectual Property | Michael Goldberg | MDV | 01:15 | 02/2006 |
| Podcast | Lessons Learned in the Life Sciences Industry | Michael Goldberg | MDV | 50:55 | 02/2006 |
| Video | Patenting Genes | Michael Goldberg | MDV | 01:23 | 02/2006 |
| Video | Role of Boards | Michael Goldberg | MDV | 02:40 | 02/2006 |
| Video | Selling a Venture | Michael Goldberg | MDV | 02:21 | 02/2006 |
| Video | Starting out as a Sole Founder | Michael Goldberg | MDV | 01:38 | 02/2006 |
Goldberg advices students and young-budding entrepreneurs to follow their passions. You have to be passionate for your company to be able to persist and face the failures that come along the way, he says.
Goldberg talks about what happens when there is a conflict between board members and the management team in terms of the direction of the company.
Goldberg talks about how understanding the importance of intellectual property, patents, trademarks and copyrights is essential in today's industries.
Michael Goldberg, General Partner at Mohr Davidow Ventures and Founder of Axion Inc., shares lessons learned through his 25 years of experience as an entrepreneur and investor in the life sciences industry.
Goldberg gives his views on whether genes should be patented along with an insight into open source biology.
Being on the boards of various companies, Goldberg gives his perspective and a sense of the flavor of what happens in board rooms and the roles of different types of boards.
Goldberg talks about the point when he sold the company that he had built for nine years. He goes on to reveal that he would do the same thing then if he knew what he knows today. He says he was happy he sold the company to a bigger company who earned larger revenues on it.
Michael Goldberg, General Partner at Mohr Davidow Ventures and Founder of Axion Inc., discusses his transition from being a venture capitalist to an entrepreneur. He left the venture capital industry to found a company. As a sole founder, he encourages everybody to start a company with at least one co-founder because it entails a difficult and lonely path.